Close Asset Management LTD Neurocrine Biosciences Inc Transaction History
Close Asset Management LTD
- $3.25 Billion
- Q3 2024
A detailed history of Close Asset Management LTD transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Close Asset Management LTD holds 268 shares of NBIX stock, worth $39,859. This represents 0.0% of its overall portfolio holdings.
Number of Shares
268
Previous 268
-0.0%
Holding current value
$39,859
Previous $37,000
16.22%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding NBIX
# of Institutions
634Shares Held
94.1MCall Options Held
632KPut Options Held
621K-
Black Rock Inc. New York, NY14.2MShares$2.11 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA10MShares$1.49 Billion0.02% of portfolio
-
State Street Corp Boston, MA5.15MShares$766 Million0.02% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.57MShares$383 Million0.47% of portfolio
-
Bellevue Group Ag Kuesnacht, V81.86MShares$277 Million3.62% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $14.2B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...